HOME > BUSINESS
BUSINESS
- Enhertu Outperforms Kadcyla in PIII Breast Cancer Trial
September 30, 2025
- Alfresa, Hiroshima Univ. Hospital Begin Talks on SFTS Collaboration
September 30, 2025
- Industry Fears Trump’s MFN Drug Pricing Push Could Deepen Japan’s Lag and Loss
September 29, 2025
- Riken Genesis CDx Earns Japan Nod for Truqap Combo Therapy
September 29, 2025
- Meiji Rolls Out 2-Dose Vial of COVID-19 Vaccine Kostaive
September 29, 2025
- Mochida Sees Domestic Biosimilar Supply Gains in And Pharma Tie-Up
September 26, 2025
- Fujifilm Launches US$3.2 Billion Biologics Plant in North Carolina
September 26, 2025
- MEDRx/DWTI Clinch US FDA Approval for Lidocaine Patch
September 26, 2025
- Nippon Zoki Shooting for 50% Overseas Sales by FY2035
September 25, 2025
- Australia Clears Leqembi after Tribunal Review
September 25, 2025
- Taiho Hooks Up with Guardant Health in Biomarker Search
September 25, 2025
- GE HealthCare to Develop Lantheus’ Prostate Cancer PET Agent in Japan
September 25, 2025
- Eisai Settles US Lenvima Suit with Dr. Reddy’s, Generic Launch Barred Until 2030
September 25, 2025
- Enhertu Combo Accepted for US Review in First-Line HER2 Breast Cancer
September 25, 2025
- Chugai Seeks Avastin Label Expansion for Neurofibromatosis Type 2
September 25, 2025
- Mochida and Itochu to Each Take 20% Stake in And Pharma
September 24, 2025
- PharmaEssentia Files for ET Indication of Besremi in Japan
September 24, 2025
- FDA Turns Down Otsuka’s PTSD Bid for Rexulti
September 24, 2025
- Moderna Rolls Out LP.8.1-Tailored Spikevax in Japan
September 24, 2025
- Nikon Bets 10 Billion Yen on Regenerative Medicine CDMO Push
September 22, 2025
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
